RSS

antimicrobial resistance (AMR)

EPM editor Reece Armstrong writes why international efforts are essential for global health concerns like AMR and vaccination. Read more

Opinion

A new global group has been formed by a range of life science organisations to help combat the threat of antimicrobial resistance (AMR). Read more

News

A new genetic test has been developed to help determine whether people carry bacteria that can cause resistance to two common antibiotics. Read more

News

A European-wide project has been launched to combat antimicrobial resistance (AMR) in community care settings. Read more

News

One of the UK’s leading bodies for helping fight antimicrobial resistance has received a significant funding boost. Read more

News

UK-based biotech company Procarta Biosystems has received €1.5 million funding to help it develop novel therapies to combat antimicrobial resistance (AMR). Read more

News

Darius Hughes, head of vaccines at Pfizer UK, writes about the UK government’s new plan on controlling antimicrobial resistance (AMR). Read more

Opinion

Medical device organisation MediSieve is receiving two grants from Innovate UK for two-year projects beginning this year, totalling £1.56 million. Read more

News

Antimicrobial resistance (AMR) is one of the biggest threats facing the world but arguably not enough is being done by both pharma companies and governments around the world. Read more

Opinion

A new reimbursement model for antibiotics by the NHS and NICE is being labelled as a ‘great breakthrough’. Read more

News

With the potential of antimicrobial resistance (AMR) taking our modern medicine practices back to the stone age, governments around the world need to face the threat head on. Read more

Opinion

A new collaboration between the University of California, Los Angeles and biopharmaceutical company Helperby is looking to develop the next generation of combination antibiotics. Read more

News

A collection of 36 life science organisations are calling on the UK government to address both the £500 million research funding gap and the chronic shortage of scientists working on new antibiotics. Read more

News

The International Federation of Pharmaceutical Manufacturers and Associations has called upon governments across the world to put in place R&D incentives for biopharmaceutical companies developing ways to tackle antimicrobial resistance (AMR). Read more

News

The AMR Industry Alliance has reaffirmed its pledge to raise awareness amongst policy-makers, healthcare professionals and the general public about the threat of antimicrobial resistance (AMR). Read more

News

In his first Editor's Desk focus, Reece Armstrong asks whether it's time pharmaceutical manufacturers change their approaches to the way drugs are developed, in response to changing healthcare needs around the world. Read more

Latest Issue

Antimicrobial resistance (AMR) needs to become a ‘top-five policy priority’ by the UK government if the virtual loss of modern medicine is to be stopped, a new report has said. Read more

News

In this article, Adrian Fellows, head of R&D at AGA Nanotech, looks at the current state of play in the global antimicrobial resistance crisis, revealing that we need solutions — like delivering high-energy oxidative molecules in a controlled manner Read more

Opinion

As the UK enjoys a prolonged period of hot and sunny weather, a threat is becoming apparent in the form of serious infection due to horsefly bites, according to the charity, Antibiotic Research UK (ANTRUK). Read more

News

A Small Business Research Initiative (SBRI) competition has been launched by the government to encourage development of innovative solutions to the antimicrobial resistance (AMR) crisis in humans. Read more

News